Why the study?
Does good adherence to class-I recommended medications reduce potentially preventable heart failure hospitalizations in younger adults with newly diagnosed heart failure?
Does good adherence to class-I recommended medications reduce potentially preventable heart failure hospitalizations in younger adults with newly diagnosed heart failure?
Good adherence to guideline-directed medical therapy is associated with a reduced risk of preventable heart failure hospitalizations in younger adults.
Supports adherence monitoring in younger adults with new HF; hypothesis-generating and should not yet change practice.
We found that approximately half of insured U.S. adults aged 18-64 years with newly diagnosed HF had good adherence to their HF medications. Patients with good adherence, compared to those with poor adherence, were less likely to have a potentially preventable HF hospitalization 3-5 years after their initial diagnosis. Because HF is a chronic condition that requires long-term management, future studies may want to assess the effectiveness of interventions in sustaining adherence.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: